pHAGE-ERBB2 Citations (3)

Originally described in: Systematic Functional Annotation of Somatic Mutations in Cancer.
Ng PK, Li J, Jeong KJ, Shao S, Chen H, Tsang YH, Sengupta S, Wang Z, Bhavana VH, Tran R, Soewito S, Minussi DC, Moreno D, Kong K, Dogruluk T, Lu H, Gao J, Tokheim C, Zhou DC, Johnson AM, Zeng J, Ip CKM, Ju Z, Wester M, Yu S, Li Y, Vellano CP, Schultz N, Karchin R, Ding L, Lu Y, Cheung LWT, Chen K, Shaw KR, Meric-Bernstam F, Scott KL, Yi S, Sahni N, Liang H, Mills GB Cancer Cell. 2018 Mar 12;33(3):450-462.e10. doi: 10.1016/j.ccell.2018.01.021. PubMed Journal

---

Articles Citing pHAGE-ERBB2

Articles
Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma. Rogerson C, Ogden S, Britton E, Ang Y, Sharrocks AD. Elife. 2020 Sep 3;9:e57189. doi: 10.7554/eLife.57189. PubMed
Downregulation of miR-375 contributes to ERBB2-mediated VEGFA overexpression in esophageal cancer. Ren S, Tan X, Fu MZ, Ren S, Wu X, Chen T, Latham PS, Lin P, Man YG, Fu SW. J Cancer. 2021 Oct 20;12(23):7138-7146. doi: 10.7150/jca.63836. eCollection 2021. PubMed
Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer. Pereira PMR, Mandleywala K, Monette S, Lumish M, Tully KM, Panikar SS, Cornejo M, Mauguen A, Ragupathi A, Keltee NC, Mattar M, Janjigian YY, Lewis JS. Nat Commun. 2022 May 9;13(1):2526. doi: 10.1038/s41467-022-30142-9. PubMed

If you have published an article using this material, please email us at to have your article added to this page.